How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
Top Cited Papers
Open Access
- 22 February 2020
- Vol. 12 (2), 514
- https://doi.org/10.3390/cancers12020514
Abstract
Adenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors (PitNET), are mostly benign, but may present various behaviors: invasive, “aggressive” and malignant with metastases. They are classified into seven morphofunctional types and three lineages: lactotroph, somatotroph and thyrotroph (PIT1 lineage), corticotroph (TPIT lineage) or gonadotroph (SF1 lineage), null cell or immunonegative tumor and plurihormonal tumors. The WHO 2017 classification suggested that subtypes, such as male lactotroph, silent corticotroph and Crooke cell, sparsely granulated somatotroph, and silent plurihormonal PIT1 positive tumors, should be considered as “high risk” tumors. However, the prognostic impact of these subtypes and of each morphologic type remains controversial. In contrast, the French five-tiered classification, taking into account the invasion, the immuno-histochemical (IHC) type, and the proliferative markers (Ki-67 index, mitotic count, p53 positivity), has a prognostic value validated by statistical analysis in 4 independent cohorts. A standardized report for the diagnosis of pituitary tumors, integrating all these parameters, has been proposed by the European Pituitary Pathology Group (EPPG). In 2020, the pituitary pathologist must be considered as a member of the multidisciplinary pituitary team. The pathological diagnosis may help the clinician to adapt the post-operative management, including appropriate follow-up and early recognition and treatment of potentially aggressive forms.Keywords
This publication has 97 references indexed in Scilit:
- ACTH‐secreting Crooke cell carcinoma of the pituitaryEuropean Journal of Clinical Investigation, 2012
- Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatmentClinical Endocrinology, 2012
- Atypical pituitary adenomas: incidence, clinical characteristics, and implicationsJournal of Neurosurgery, 2011
- Silent subtype 3 carcinoma of the pituitary: a case reportNeuropathology and Applied Neurobiology, 2010
- Silent corticotroph adenomasArchives of Endocrinology and Metabolism, 2007
- Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor RegistryActa Endocrinologica, 2007
- Pathobiology of Pituitary Adenomas and CarcinomasNeurosurgery, 2006
- Silent Adenoma Subtype 3 of the Pituitary—Immunohistochemical and Ultrastructural Classification: A Review of 29 CasesUltrastructural Pathology, 2005
- Expression of GATA-2 in Human Pituitary AdenomasLaboratory Investigation, 2002
- Human pituitary gonadotropic adenoma; histological, immunocytochemical, and ultrastructural and hormonal studies in eight casesThe Journal of Pathology, 1981